Merck's pending drug is attracting veterinarian interest, while Stifel downgraded Zoetis stock to Hold.

The entities involved

• Zoetis →

  American animal health company

  Nothing else this week.

• Merck →

  public company in Indonesia

  • Eli Lilly, Novo Nordisk, and Merck are currently competing in the highly competitive GLP-1 obesity market.Sat 17:22
  • Merck will share clinical trial results at the American Academy of Ophthalmology (AAO) meeting.Fri 18:13
• Stifel →

  American investment bank

  • China and Stifel are currently top suppliers in the critical minerals market, with their market actions showing a preference for producers located outside of China.Mon 00:03
  • AI stocks are benefiting from Trump-era tariffs, and Brian Schwartz maintained an Outperform rating on Workday on September 5th.Sun 01:33

Related events

• Merck's stock price increased following positive drug performance involving Summit Therapeutics.Sep 3
• Merck's Animal Health segment is performing well, and the company discussed transformation during a meeting with Morgan Stanley.Sep 14
• Stifel reiterated a Buy rating and target price for Spyre Therapeutics, while Deutsche Bank lowered targets following company results.Sep 1
• Merck has set the list price for a drug that received approval from the FDA.Aug 31